Table 3.
Poseidon 1 | Poseidon 2 | Poseidon 3 | Poseidon 4 | Control | ANOVA | |
---|---|---|---|---|---|---|
(n = 14) | (n = 8) | (n = 6) | (n = 22) | (n = 19) | P | |
Testosterone (ng/mL) | 1.76 ± 0.25 | 2.12 ± 0.35 | 2.09 ± 0.76 | 2.06 ± 0.45 | 2.34 ± 0.68 | NS |
Androstenedione (ng/mL) | 14.41 ± 2.18 | 20.24 ± 3.78 | 15.25 ± 7.33 | 18.95 ± 3.35 | 25.52 ± 6.22 | NS |
DHEA-S (μg/dL) | 178.08 ± 24.37b | 146.09 ± 28.46 | 66.43 ± 17.52a | 123.27 ± 12.11 | 171.60 ± 16.96 | 0.009 |
Estradiol (ng/mL) | 468.21 ± 359.79 | 316.66 ± 294.71 | 554.62 ± 390.00 | 251.45 ± 131.52 | 191.22 ± 171.09 | NS |
SHBG (nmol/L) | 83.02 ± 11.67 | 101.89 ± 29.85 | 49.05 ± 10.89 | 49.28 ± 6.19 | 91.06 ± 12.44 | NS |
IGF-1 (ng/mL) | 234.65 ± 29.57 | 218.99 ± 27.37 | 229.17 ± 63.08 | 227.75 ± 24.56 | 199.46 ± 21.91 | NS |
Values are expressed as mean ± SEM.
p < 0.05 vs. Control.
p < 0.05 vs. Poseidon 3.
Statistical significance using ANOVA withTukey post-hoc test.